Microbiology & Infectious Diseases

A novel clinical decision support system, TBorNotTB, has been developed to assist clinicians in diagnosing pulmonary tuberculosis in low-prevalence settings.

Women are at a significantly higher risk of developing long COVID compared to men, especially between the ages of 40–55 years.

The CROSS score has been developed to accurately predict the risk of intensive care unit admission for patients with COVID-19 who present at the emergency room.

A decade-long study has shed light on the risks of hepatitis D virus superinfection in people with HIV co-infected with hepatitis B virus.

Research reveals that 15% of children aged 0–35 months in the USA received at least one invalid vaccine dose between 2011–2020.

The ongoing RECOVER-Adult study reveals that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops significantly more frequently following SARS-CoV-2 infection.

Using a procalcitonin-guided algorithm does not significantly reduce duration of IV antibiotic treatment in children with bacterial infections.

A recent study has identified a previously unknown antibody target on the Plasmodium falciparum sporozoite surface.